Evotec (NASDAQ:EVO) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.06) by 150 percent. This is a 15.38 percent decrease over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $166.802 million which missed the analyst consensus estimate of $212.370 million by 21.46 percent. This is a 14.08 percent decrease over sales of $194.147 million the same period last year.